List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 16 studies with search of: DIMETHYL SULFOXIDE
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Terminated Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)
Conditions: Interstitial Cystitis;   Bladder Diseases
Interventions: Drug: dimethyl sulfoxide;   Drug: IC Cocktail
2 Recruiting Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Other: Hyperbaric Oxygen Therapy;   Drug: DMSO
3 Unknown † Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: incomplete Freund's adjuvant;   Biological: multi-epitope melanoma peptide vaccine;   Biological: sargramostim;   Biological: tetanus toxoid helper peptide;   Drug: dimethyl sulfoxide;   Drug: imiquimod;   Procedure: adjuvant therapy
4 Terminated A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Condition: HIV Infections
Interventions: Biological: Opal-HIV-Gag(c) Low Dose;   Biological: Opal-HIV-Gag(c) Medium dose;   Biological: Opal-HIV-Gag(c) High dose;   Other: Dimethyl Sulfoxide
5 Active, not recruiting Over Active Bladder Instillation Study - Botox
Conditions: Overactive Bladder;   Urinary Urge Incontinence;   Urinary Incontinence;   Detrusor Hyperreflexia;   Urge Incontinence
Interventions: Procedure: Botox Instillation;   Procedure: Placebo Instillation
6 Recruiting DMSO Efficacy in IC/PBS Patients During and After Treatment
Condition: Cystitis, Interstitial
Intervention: Drug: DMSO cocktail
7 Active, not recruiting Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
Condition: Actinic Keratosis
Interventions: Drug: 5-aminolevulinic acid + red lamp;   Drug: Cryotherapy with liquid nitrogen
8 Completed Botulin-A Toxin Instillations and Overactive Bladder
Conditions: Overactive Bladder;   Detrusor Instability;   Detrusor Hyperreflexia of Bladder
Intervention: Drug: Botox/DMSO
9 Completed Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study
Condition: Knee Osteoarthritis
Intervention: Dietary Supplement: Methylsulfonylmethane (MSM)
10 Active, not recruiting Effects of Pennsaid on Clinical Neuropathic Pain
Conditions: Neuralgia;   Postherpetic Neuralgia;   Reflex Sympathetic Dystrophy
Interventions: Drug: Pennsaid topical 1.5% diclofenac;   Drug: Placebo (2.3% DMSO solution)
11 Completed Evaluation of Toxicity From Stem Cell Transplant
Conditions: Organ Dysfunction;   Hemolysis
Intervention:
12 Completed Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease
Condition: Temporomandibular Degenerative Joint Disease.
Interventions: Drug: 1.5% diclofenac in 45.5% DMSO (topical treatment);   Drug: 45.5% DMSO (topical placebo)
13 Completed DMSO-PDT of BCC - A 6 Year Follow Up
Condition: Carcinoma, Basal Cell
Intervention:
14 Not yet recruiting A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
Condition: Metastatic Renal Cell Carcinoma
Intervention: Biological: Combig-DC (allogeneic dendritic cells) Cancer Vaccine
15 Recruiting Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma Non-small Cell Lung Cancer Stage IIIA;   Carcinoma Non-small Cell Lung Cancer Stage IIIB;   Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator
16 Completed Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Prochymal™ adult human mesenchymal stem cells;   Drug: adult human mesenchymal stem cells

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services